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Summary and Future Research Needs
by P. A. Bromberg* and D. B. Menzelt
Dr. Bromberg: This is a remarkable meeting in
that, with very few exceptions, almost no mention
was made of pulmonary mechanics and of gas ex-
change. That doesn't happen very often in meetings
devoted primarily to lung research, but perhaps has
been happening more frequently in the recent past
and it may indicate a trend for the future. Another
interesting note was that almost everyone is working
or collaborating with an ultrastructuralist, or would
like to have access to ultrastructural techniques. Dr.
Reid, among others, gave us a very nice demonstra-
tion of how ultrastructural techniques can be com-
bined with biochemical techniques in experimental
studies ofthe reaction ofthe lung to insults. Dr. Satir
presented most elegant ultrastructural biochemical
data on the mechanism of ciliary motion.
The organization of the meeting, as I perceive it,
looks at the lung as having three segments. There
was a large area ofattention to the epithelium, and at
the end, there was a large area of attention to the
endothelium. Inthe middle, I suppose appropriately,
there were a number of speakers who talked about
cells that more or less fit between the epithelium and
the endothelium. Notably missing, or in large mea-
sure missing, werediscussions ofsmooth muscle and
of neural function at more than a passing level. The
keynote of the epithelial sections was set by Dr.
Boucher and Dr. Gatzy, who pointed to the barrier
function ofthe epithelium and the attempts to quan-
titate the nature and the site ofthisbarrier. They paid
special attention tothe intercellularjunctions and the
so-called tight junctions of the epithelium and de-
fined their properties by electrical measurements
and by using a variety of non-charged probe
molecules.
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Ofparticular importance are the macromolecules
which may gain access to important cells residing
deep in the epithelium. These cells were discussed
by Dr. Bienenstock, Dr. Brain, and Dr. Wasserman.
These powerful cells - Dr. Spitznagel's cell, the
poly, the mast cell of Dr. Wasserman, and the "big
Mac" of Dr. Brain - have an enormous armamen-
tarium. It's important to consider how materials de-
posited in the airway may or may not be able to gain
access to these cells, and how environmental pollu-
tants and toxic agents might alterthebarrierfunction
of the epithelium and permit more ready access of
other inhaled materials to these critical cells, which
when turned on have the potential not only for pro-
tective action, but apparently for very damaging ac-
tions. We were shown by Dr. Wasserman in par-
ticular, and other speakers as well, the remarkable
balance between active effects and mechanisms
which repair or inhibit these effects.
This underlies a big problem that the EPA faces in
trying to develop its research program. It may be
relatively easy to showeffectsofone sortoranother,
but at what point do these effects go from the normal
range or the range that can be dealt with by intrinsic
mechanisms tothe point where you have disease. To
dothis, one mustbearin mind theintrinsic variability
ofthe human subject. The fact that some of us have
less hairthan others and some ofus have brown eyes
while others have blue eyes is obvious. Butthere are
many other differences of which we're perhaps less
aware that make some of us more susceptible to
certain insults than others, because our compensa-
tory mechanisms are not as effective. A stress that
can be easily tolerated by one individual may be-
come a stress thatproduces overtdisease inanother.
Even though the EPA is a regulatory agency and will
continue to look on its role in research as developing
data that directly abut on its regulatory function, the
Agency must bear in mind that it is important to
understand mechanisms to the extent that one can
predict idiosyncrasies and unusual reactions that
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stress. To do this "blindly" using empirical pro-
tocols is impossible. There are too many agents to be
tested and too many possible protocols. To do well-
directed, intelligent, pertinent experiments, one has
tohave some reasonable conceptions ofmechanism.
Another problem that the EPA in particular has to
face is that the payoff is human effects. Yet, the
experiments that can be performed in man are lim-
ited. At this symposium scientists have described to
us systems that are very complex and far removed
from the intact human being. But there are other
techniques that are either directly applicable or po-
tentially applicable to intact human subjects. We
should make efforts to develop techniques that can
be used in human subjects, and to apply them. For
example, in studying tracheal tissue one can look at
rats and hamsters, and soforth, butit isalso possible
with a fiberoptic bronchoscope to obtain samples of
tracheal epithelium. Such epithelium can be cultured
successfully. Dr. Collier has done so by using speci-
mens that we have provided for him during ordinary
bronchoscopies inclinical practice. He hasbeen able
to show by using such materials thatthese specimens
can be maintained for many days, that they retain
ciliary activity, that they can be infected by a variety
ofspecific infectious agents, that characteristic mor-
phologic pictures can be produced, and that these
pictures are different from what is seen when one
uses the same infectious agents in animal models.
It's going to be important to try as much as possible
to use human tissue, even for in vitro experiments.
Dr. Boucher has shown us techniques that can be
applied to intact animals, and a few steps have been
made to apply them to intact humans, in whom one
can measure one ofthe bioelectric parameters ofthe
airways epithelium, and one can even induce local
changes by the local application of very minute
quantities ofdrugs. Other examples could be given.
We also need to bear in mind the potential applica-
tion of our techniques to human studies and the use
of human tissue as much as possible in our experi-
ments.
This is a very exciting era in lung biology; people
with all kinds ofbackground and training have been
stimulated in a variety ofways to look at the lung as
more than an organ that simply deals with shuttling
air in and out, and transferring oxygen to the blood,
and C02 out ofthe blood. I foresee that this kind of
research is goingto be ofincreasing importance to all
aspects ofgovernment activity, to the NIH, NIEHS,
and also tothe EPA. It will take some ingenuity to do
the right kindofexperiments certainly, butit isgoing
to take an attitude on the part ofthe EPA, in particu-
lar, not to disregard mechanism infavorofwhat may
seem to be the short-term payoff of defining levels
that are or are not "toxic." To do the latterjob well
will require some very clever application of the
knowledge ofmechanisms, and that is the plea that I
would like to leave with you.
Dr. Menzel: We've seen here the beginnings of a
new era in pulmonary research. It is directed to the
definition ofthe normal physiologic state ofthe lung,
emphasizing both respiratory and nonrespiratory
metabolism. In defining the pathophysiologic state,
mechanisms ofaction must be known so that altera-
tions in particular values may be recognized as ab-
normal. Since biochemical measurements often are
more sensitive than morphologic changes, connec-
tions between altered morphology and altered
physiology must be sought. Unfortunately, the biol-
ogy of the lung is but poorly understood. Much ef-
fort, then, is being expended on basic or baseline
data to increase our surety that the measured effect
on exposure to an environmental pollutant is indeed
abnormal and hence toxic. To these ends our tools
are still blunt and need to be honed to as fine an edge
as possible.
Controversy surrounds the use of animal data in
assessing human toxicity. Much of this discord re-
sults from the pioneer state of lung research. To be
sure, there are differences between man and ani-
mals, especially in the morphology of the lung. But
there are far fewer differences in the basic
physiologic processes as seen here forion transport,
metabolism of xenobiotic compounds, and the up-
take and metabolism ofprostaglandins, angiotensin,
and biogenic amines. On this scale the difference
between animals and man is one of dose.
Morphology is highly important, as evidenced by
the heavy collaboration between physiologists,
pharmacologists, and morphologists. One approach
has been to eliminate morphology by studying pure
systems. Here the biochemistries ofthe hepatic and
pulmonary systems of cytochrome P450, for ex-
ample, are remarkably similar. Tissue specificity is
expressed inthe molecularforms ofcytochrome P450
present in the lung and the differences in inducibility
by environmental agents. The uptake mechanisms
unique to the lung are likely, however, to encourage
recycling and higher concentrations of reactive in-
termediaries than in the liver. This may make the
lung more susceptible to both environmental car-
cinogens and toxicants acting through activated in-
termediaries which bind covalently to cell mac-
romolecules. Thebiochemistry andpharmacology of
the lunghasbeenaided by the isolation andculture of
both organs and specific cells. Much more work is
needed here to identify susceptible lung cells and to
develop specific markers, enzymatic or glycopro-
tein, indicative of pulmonary damage. Release of
marker enzymes by the liver and heart has been
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damage by toxicants and myocardial damage by is-
chemia in the clinical assessment of man. Similar
techniques are likely for pulmonary damage.
The development of ex vivo and in vivo perfused
lung preparations has been accomplished in the last
five years. It is now possible to study the transient
events ofprostaglandin metabolism which had been
obscured by competing factors and compensatory
mechanisms in intact preparations. Of particular
note are the studies relating S02 to bronchitis and the
consequences ofaberrant prostaglandin metabolism
in asthmatics. Perhaps here we will understand some
of the more subtle effects seen in man on lifetime
exposure to polluted air.
We cannot lose sight of the fact that regulation of
pollution is the ultimate aim to which these studies
will be applied. Therefore, it is important to define
the point at which an effect ceases to become a
normal response and becomes pathophysiologic. It
is also necessary to attempt to extrapolate these
measurements made in animals to the human condi-
tion in a manner which is defensible and at the same
time sensitive. Certainly the question ofthe variabil-
ity of man in regard to his response is particularly
important. This integration is represented by the or-
ganization ofthis meeting. It represents the philoso-
phy of those within the Health Effects Research
Laboratory with whom I have had the pleasure to
work, starting with Dr. Gordon Hueter, Director of
HERL, and Dr. William Durham and represented at
this symposium by Dr. D. E. Gardnerand Dr. Ed Hu
and their colleagues. Certainly, they recognize the
need for the development ofmethods that are sensi-
tive, the application of new methods, and the inte-
gration of these to toxic exposures which are rele-
vant to the exposure ofman in the environment and
ultimately to the prevention of disease. This par-
ticularmissionisdeservingofthefinestresearchthat
we can bring to the issue. I am very pleased to have
beenabletoassociate with you indemonstrating that
it is possible to bring together high quality, thesis-
directed research in the application to inhalation
toxicology.
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